Johan Vingerhoets Selected Research

Proteins (Proteins, Gene)

1/2023	Genotypic and phenotypic characterization of influenza A viral variants in study participants treated with pimodivir in the phase 2b TOPAZ study.
1/2023	Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity.
12/2020	Pharmacokinetics, Safety, and Antiviral Effects of Multiple Doses of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678, in Infants Hospitalized With RSV Infection: A Randomized Phase 1b Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johan Vingerhoets Research Topics

Disease

5	Infections 01/2023 - 01/2010
4	COVID-19 03/2024 - 01/2022
4	Human Influenza (Influenza) 01/2023 - 01/2018
3	Exanthema (Rash) 10/2010 - 11/2009
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2010 - 11/2009
1	Virus Diseases (Viral Diseases) 01/2023
1	HIV Infections (HIV Infection) 01/2023
1	Breakthrough Infections 12/2022
1	Respiratory Syncytial Virus Infections 12/2020
1	Vaccinia 01/2020
1	Disease Progression 03/2002

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 03/2024 - 01/2022
4	Ad26COVS1IBA 03/2024 - 01/2022
4	pimodivirIBA 01/2023 - 01/2018
4	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2020
3	Oseltamivir (Tamiflu)FDA Link 01/2023 - 01/2019
3	etravirine (TMC-125)FDA Link 10/2010 - 11/2009
2	AntigensIBA 01/2023 - 01/2020
1	Human Immunodeficiency Virus ProteinsIBA 01/2023
1	AntibodiesIBA 01/2023
1	AIDS VaccinesIBA 01/2023
1	IntegrasesIBA 01/2023
1	JNJ-53718678IBA 12/2020
1	Influenzavirus A PB2 proteinIBA 01/2019
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2010
1	CC ChemokinesIBA 03/2002

Therapy/Procedure

1	Injections 12/2022
1	Aftercare (After-Treatment) 01/2020
1	Therapeutics 01/2020